This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Novel markers in pediatric-type follicular lymphoma
Virchows Archiv Open Access 04 November 2019
-
Chlamydia psittaci in ocular adnexa MALT lymphoma: a possible role in lymphomagenesis and a different geographical distribution
Infectious Agents and Cancer Open Access 02 April 2012
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Streubel B, Vinatzer U, Lamprecht A, Raderer M, Chott A . T(3;14)(p14.1;q32) involving IGH and FOXP1 is a novel recurrent chromosomal aberration in MALT lymphoma. Leukemia 2005; 19: 652–658.
Wlodarska I, Veyt E, De Paepe P, Vandenberghe P, Nooijen P, Theate I et al. FOXP1, a gene highly expressed in a subset of diffuse large B-cell lymphoma, is recurrently targeted by genomic aberrations. Leukemia 2005; 19: 1299–1305.
Fenton JA, Schuuring E, Barrans SL, Banham AH, Rollinson SJ, Morgan GJ et al. t(3;14)(p14;q32) results in aberrant expression of FOXP1 in a case of diffuse large B-cell lymphoma. Genes Chromosomes Cancer 2005; 45: 164–168.
Jaffe ES, Harris NL, Stein H, Vardiman JW (eds). World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC Press, 2001.
Hans CP, Weisenburger DD, Greiner TC, Gascoyne RD, Delabie J, Ott G et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 2004; 103: 275–282.
Banham AH, Connors JM, Brown PJ, Cordell JL, Ott G, Sreenivasan G et al. Expression of the FOXP1 transcription factor is strongly associated with inferior survival in patients with diffuse large B-cell lymphoma. Clin Cancer Res 2005; 11: 1065–1072.
Barrans SL, Fenton JA, Banham A, Owen RG, Jack AS . Strong expression of FOXP1 identifies a distinct subset of diffuse large B-cell lymphoma (DLBCL) patients with poor outcome. Blood 2004; 104: 2933–2935.
Bea S, Zettl A, Wright G, Salaverria I, Jehn P, Moreno V et al. Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction. Blood 2005; 106: 3183–3190.
Acknowledgements
We thank Dr PJ Brown, I Eichelbrönner and H Brűckner for their excellent technical assistance.
AHB is and RV was supported by the Leukemia Research Fund. EH, GO, AR and HKM-H are supported by the Deutsche Krebshilfe Grant 70-3173-Tr3. AR is supported by the Interdisciplinary Center for Clinical Research (IZKF) of the University of Würzburg.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Haralambieva, E., Adam, P., Ventura, R. et al. Genetic rearrangement of FOXP1 is predominantly detected in a subset of diffuse large B-cell lymphomas with extranodal presentation. Leukemia 20, 1300–1303 (2006). https://doi.org/10.1038/sj.leu.2404244
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2404244
This article is cited by
-
Novel markers in pediatric-type follicular lymphoma
Virchows Archiv (2019)
-
Reciprocal expression of the endocytic protein HIP1R and its repressor FOXP1 predicts outcome in R-CHOP-treated diffuse large B-cell lymphoma patients
Leukemia (2014)
-
Chlamydia psittaci in ocular adnexa MALT lymphoma: a possible role in lymphomagenesis and a different geographical distribution
Infectious Agents and Cancer (2012)